Peripheral Nerve Stimulators Market: Increasing Neurological Disorder is Likely to Positively Affect Growth by 2032

Market Research Future (MRFR) has published on the “Global Peripheral Nerve Stimulators Market”.

The Peripheral Nerve Stimulators market is estimated to register a CAGR of 6.65% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the Peripheral Nerve Stimulators Market— MEDTRONIC (Ireland), B. Braun SE (Germany), Boston Scientific Corporation (US), Curonix LLC (US), SPR Therapeutics (US), AVNS (US), Teleflex Incorporated (US), SUNMED(US), Xavant Technology (Pty) Ltd (South America), Vygon (France)

Peripheral Nerve Stimulators Market Highlights

The Global Peripheral Nerve Stimulators market is expected to register a CAGR of 6.65% during the forecast period and is estimated to reach USD 0.91 billion by 2032.

The Peripheral nerve stimulation, commonly known as PNS, is a frequently used technique for treating chronic pain. According to Peripheral nerve injuries (PNI) are mainly caused by surgery and trauma and are common in clinical practice, with 13 to 23 per 1,00,000 people typically suffering from PNI.The growth of the peripheral nerve stimulators market is driven by the increasing demand for such stimulators, the rise in nerve injury cases, and the growing popularity of wireless peripheral nerve stimulators.

However, the market growth is likely to be restrained by high costs of products and stringent regulatory requirements. On the other hand, growing incidences of road accidents and growing geriatric population is expected to create lucrative growth opportunities for players operating in the Peripheral Nerve Stimulators market.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Peripheral Nerve Stimulators Market Research Report

Segment Analysis

The Peripheral Nerve Stimulators market has been segmented based on product, device type, stimulating feature and end-user.

On the basis of product, the market is segmented into transcutaneous, percutaneous, and implantable. Transcutaneous peripheral nerve stimulators (TPNS) accounted for the largest market during the forecast period. The TPNS devices provide non-invasive therapeutics without any side effects. This is primarily used to treat arthritis, back and neck pain, fibromyalgia, muscle pain, and neuropathic pain. The increasing incidences of these above-mentioned diseases are increasing the demand for TPNS stimulators, driving the segment's growth. Moreover, percutaneous peripheral nerve stimulation (PNS) segment growth is driving owing to the high demand for the treatment of neuropathic pain.

On the basis of the device, the market is segmented into stimulator machines with trains of four (TOF) monitoring features and machines without TOF features. The pain pump segment held the largest market in 2022 and is also the fastest growing segment during the forecast period.  A pain pump is attached to the catheter and delivers medication to a specific point. The pain pump is mostly used for multiple sclerosis and cerebral palsy. The stimulator’s segment growth is due to the increasing contributions of market players. Furthermore, continuous peripheral nerve block (CPNB) catheters are majorly used in the ambulatory surgical centers which provide a prolonged block to pain. Moreover, the increasing demand for the product, frequent launches, and distribution across the globe are propelling the CPNB segment growth.

On the basis of stimulating features, the market is segmented into. The stimulator machines with TOF monitoring features is the largest and fastest growing segment during the forecast period. The stimulator machines with TOF monitoring features are utilized to assess neuromuscular transmission while delivering a neuromuscular blocking agent. These are mostly used in intraoperative and postoperative procedures, including orthopedic surgery, to assess drug delivery. As per the Arthritis Society of Canada, there will be 6 million people with arthritis in Canada in 2020, which is 1 in 5 people. Moreover, machines without TOF features include single-twitch and tetanic stimulators. The market players are launching products based on precision stimulation in order to fulfil the demand of their customers, especially physicians, to assist them during intraoperative procedures.

On the basis of end user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. Hospitals & clinics accounted for the largest market share and fastest growing segment during the forecast period owing to the increasing prevalence of neurological diseases and government support through the Medicare plan for patients. Moreover, ambulatory surgery center growth is attributed to the increasing number of surgical procedures and advanced technology-based products. Moreover, in several studies, it has been mentioned that stimulator machines with TOF monitoring features are most common and are mostly used in ambulatory surgical centers during intraoperative and postoperative periods.

Regional Analysis

The Peripheral Nerve Stimulators market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Peripheral Nerve Stimulators market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Peripheral Nerve Stimulators market Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The rest of the world Peripheral Nerve Stimulators service providers market comprises of Middle East, Africa, and Latin America.

The market for Peripheral Nerve Stimulators in North America has the most share (38.08%) in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.23% to reach over USD 0.34 billion by 2032.  Peripheral Nerve Stimulators have a bright future in North America, with steady expansion predicted. Further market expansion is anticipated because of investments in healthcare infrastructure and rising public awareness of modern medical treatments. Thanks to technology improvements, both established businesses and newcomers are well-positioned to take advantage of these opportunities and address the growing need for better results.

The Europe peripheral nerve stimulators’ market is currently undergoing substantial growth, driven by a confluence of factors that include technological advancements, an aging population, and a surge in nerve injury. This dynamic landscape is witnessing notable innovations in nerve stimulator, leading to enhanced efficacy and improved patient outcomes. This transformative journey aligns with broader goals of advancing healthcare technologies and ensuring better outcomes, positioning Europe as a key player in the global market and contributing to the ongoing enhancement of healthcare delivery and patient well-being across the continent.

Furthermore, The Asia-pacific Peripheral Nerve Stimulators market accounted for USD 0.11 billion in 2023 and is projected to grow at a CAGR of 7.59% during the forecast period. The Asia Pacific peripheral nerve stimulator market is projected to experience significant growth in the coming years. Factors such as the increasing demand of nerve stimulators, rising prevalence of neurovascular diseases, and technological advancements are expected to drive market growth. The market is also being expanded by the aging population, who are more prone to nerve injury.

The market for Peripheral Nerve Stimulators in the Rest of the World was valued at USD 0,07 billion in 2022 and is expected to grow with a compound annual growth rate (CAGR) of 5.79%. The Rest of the World market is divided into Middle East, Africa, and Latin America.  Peripheral Nerve Stimulators are in high demand due to their important role in reducing blood loss and ensuring effective wound closure during various surgical procedures. Furthermore, the development of advanced technologies and continuous product innovation are driving the growth of the market, improving the overall effectiveness of medical solutions. In these regions, demand for effective neurovascular therapies is steadily increasing due to the increasing prevalence of neurovascular diseases (such as epilepsy, brain stroke, and cerebral aneurysm) and severity of diseases (such as discharge and surrounding disorders) in target patients, which is driving the growth curve for the Asia-Pacific peripheral nerve stimulators market. Moreover, due to the increasing prevalence and awareness of the importance of these diseases, numerous equipment or devices have been developed or are undergoing clinical studies.

Key Findings of the Study

• The Peripheral Nerve Stimulators s market is expected to reach USD 0.91 billion by 2032, at a CAGR of 6.65% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market.


• Based on Device, the pain pumps ‘s segment was attributed to holding the largest market in 2022.


• Braun SE (Germany), Boston Scientific Corporation (US), Curonix LLC (US), SPR Therapeutics (US), AVNS (US)